BP
ABT icon

Ballentine Partners’s Abbott ABT Stock Holding History

Ballentine Partners’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Sell
36,598
-9,010
-20% -$822K 0.04% 146
2026
Q1 		$4.68M Sell
45,608
-5,266
-10% -$595K 0.07% 101
2025
Q4 		$6.37M Sell
50,874
-1,742
-3% -$222K 0.09% 80
2025
Q3 		$7.05M Sell
52,616
-882
-2% -$116K 0.1% 74
2025
Q2 		$7.28M Buy
53,498
+2,771
+5% +$365K 0.11% 69
2025
Q1 		$6.73M Buy
50,727
+7,189
+17% +$915K 0.12% 67
2024
Q4 		$4.92M Buy
43,538
+5,599
+15% +$647K 0.08% 83
2024
Q3 		$4.33M Buy
37,939
+3,678
+11% +$403K 0.07% 99
2024
Q2 		$3.56M Sell
34,261
-3,079
-8% -$326K 0.07% 104
2024
Q1 		$4.24M Buy
37,340
+6,466
+21% +$741K 0.08% 89
2023
Q4 		$3.4M Sell
30,874
-2,881
-9% -$288K 0.07% 99
2023
Q3 		$3.27M Buy
33,755
+1,234
+4% +$130K 0.08% 90
2023
Q2 		$3.55M Sell
32,521
-2,471
-7% -$263K 0.08% 85
2023
Q1 		$3.54M Buy
34,992
+5,422
+18% +$572K 0.09% 85
2022
Q4 		$3.25M Buy
29,570
+5,017
+20% +$519K 0.1% 79
2022
Q3 		$2.38M Buy
24,553
+1,225
+5% +$131K 0.08% 85
2022
Q2 		$2.54M Buy
23,328
+1,009
+5% +$115K 0.09% 81
2022
Q1 		$2.64M Buy
22,319
+7,813
+54% +$969K 0.08% 90
2021
Q4 		$2.04M Buy
14,506
+2,266
+19% +$290K 0.06% 108
2021
Q3 		$1.45M Buy
12,240
+635
+5% +$78K 0.05% 127
2021
Q2 		$1.35M Buy
11,605
+72
+0.6% +$8.39K 0.05% 130
2021
Q1 		$1.38M Sell
11,533
-201
-2% -$23.8K 0.05% 120
2020
Q4 		$1.28M Sell
11,734
-2,045
-15% -$222K 0.05% 120
2020
Q3 		$1.5M Buy
13,779
+203
+1% +$20.6K 0.07% 100
2020
Q2 		$1.24M Buy
13,576
+358
+3% +$32.4K 0.06% 117
2020
Q1 		$1.04M Buy
13,218
+789
+6% +$65.8K 0.06% 121
2019
Q4 		$1.08M Buy
12,429
+79
+0.6% +$6.62K 0.05% 148
2019
Q3 		$1.03M Sell
12,350
-129
-1% -$11K 0.05% 145
2019
Q2 		$1.05M Buy
12,479
+3,273
+36% +$258K 0.05% 144
2019
Q1 		$736K Sell
9,206
-1,302
-12% -$96.9K 0.04% 159
2018
Q4 		$760K Buy
10,508
+1,097
+12% +$77.1K 0.04% 147
2018
Q3 		$691K Buy
9,411
+116
+1% +$7.62K 0.04% 165
2018
Q2 		$567K Buy
9,295
+436
+5% +$26.4K 0.03% 169
2018
Q1 		$531K Sell
8,859
-64
-0.7% -$3.86K 0.03% 173
2017
Q4 		$509K Sell
8,923
-1,977
-18% -$110K 0.03% 190
2017
Q3 		$581K Sell
10,900
-538
-5% -$27K 0.03% 175
2017
Q2 		$580K Buy
11,438
+3,223
+39% +$146K 0.04% 179
2017
Q1 		$366K Buy
8,215
+683
+9% +$29.5K 0.03% 157
2016
Q4 		$290K Buy
7,532
+811
+12% +$32.2K 0.02% 153
2016
Q3 		$283K Sell
6,721
-1,182
-15% -$50.6K 0.02% 142
2016
Q2 		$311K Buy
7,903
+44
+0.6% +$1.75K 0.03% 153
2016
Q1 		$329K Sell
7,859
-189
-2% -$7.49K 0.03% 145
2015
Q4 		$361K Buy
8,048
+244
+3% +$10.8K 0.04% 124
2015
Q3 		$314K Buy
7,804
+220
+3% +$10.4K 0.03% 123
2015
Q2 		$373K Hold
7,584
– – 0.04% 113
2015
Q1 		$351K Sell
7,584
-84
-1% -$3.86K 0.03% 118
2014
Q4 		$345K Buy
7,668
+375
+5% +$16.3K 0.04% 116
2014
Q3 		$303K Buy
7,293
+700
+11% +$29.6K 0.04% 115
2014
Q2 		$269K Sell
6,593
-196
-3% -$7.7K 0.03% 118
2014
Q1 		$262K Buy
6,789
+47
+0.7% +$1.81K 0.03% 117
2013
Q4 		$259K Hold
6,742
– – 0.03% 125
2013
Q3 		$224K Buy
+6,742
New +$237K 0.03% 130

Other funds holding ABT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ballentine Partners's ABT Position: Q2 2026 in Review

Ballentine Partners reduced its Abbott (ABT) stake by 20% in Q2 2026, selling an estimated $822K and leaving 36,598 shares worth $3.32M. The position accounts for 0.04% of the portfolio, ranked #146.

Ballentine Partners first reported a position in ABT in Q3 2013 and has held it in 52 quarters since. The position peaked at $7.28M in Q2 2025. 530 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Ballentine Partners held 36,598 shares of Abbott worth $3.32M as of Q2 2026.
  • Ballentine Partners sold 9,010 Abbott shares in Q2 2026, an estimated $822K.
  • Abbott made up 0.04% of Ballentine Partners's portfolio in Q2 2026, its #146 holding.
  • Ballentine Partners first reported a position in Abbott in Q3 2013 and has held it in 52 quarters since.
  • Ballentine Partners's Abbott position peaked at $7.28M in Q2 2025.
  • 530 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.